Previously, Rac2 was shown to prevent progressive calcification in experimental atherogenesis through the suppression of Rac1-dependent IL-1β, and in CAD patients it has been found that RAC2 expression was decreased while IL-1β expression is increased (Ceneri et al., 2017). This evidence concerns the gene RAC1 and coronary artery disorder.